In the molecule of the title compound, C 14 H 16 ClN 3 O, the benzene and pyrazole rings are oriented at a dihedral angle of 3.50 (3) . In the crystal structure, intermolecular N-HÁ Á ÁO hydrogen bonds link the molecules into chains. Acontact between the benzene and pyrazole rings [centroid-centroid distance = 3.820 (3) Å ] may further stabilize the structure.
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3-(3-Chloroanilino)-1-(3,5-dimethyl-1H-pyrazol-1-yl)propan-1-one A. Saeed, S. Hussain and M. Bolte Comment 1,3,5-Trisubstituted pyrazoles are synthetic targets of paramount significance in the pharmacological industry, in view of the fact that such a heterocyclic moiety represents the core structure of numerous drugs including the widely prescribed Celebrex and Viagra (Elguero & Goya, 2002) . Pyrazole chemotype is structural motif of several highly potent inhibitors against coagulation factor Xa (Penning & Talley, 1997) among them Rivaroxaban (Eriksson & Quinlan, 2006) and Apixaban (Escolar et al., 2006) were selected for clinical development for the prevention and treatment of thrombotic diseases. Pyrazole 3-carboxylates were also identified as selective antagonist subtype 1PGE2 receptors (Akarca, 2005) . The pyrazole-based materials have been used as co-polymers for electroluminescent applications (Mella & Fagnoni, 1997) . We report herein the crystal structure of the title compound.
In the molecule of the title compound (Fig 1) , the bond lengths (Allen et al., 1987) and angles are within normal ranges.
Rings A (C11-C16) and B (N21/N22/C23-C25) are, of course, planar, and they are oriented at a dihedral angle of A/B = 3.50 (3)°.
In the crystal structure, intermolecular N-H···O hydrogen bonds (Table 1) link the molecules into chains (Fig. 2) , in which they may be effective in the stabilization of the structure. The π-π contact between the phenyl ring and the pyrazole ring, Cg1-Cg2 i [symmetry code: (i) 1 -x, 1 -y, -z, where Cg1 and Cg2 are centroids of the rings A (C11-C16) and B (N21/N22/C23-C25), respectively] may further stabilize the structure, with centroid-centroid distance of 3.820 (3) Å.
Experimental
The title compound was prepared by cyclocondensation of pentane-2,4-dione with corresponding 3-(3-Chlorophenylamino) propionohydrazide according to a method reported earlier (Saeed & Mumtaz, 2008 
Refinement
H atom of NH group was located in difference Fourier map and refined isotropically. The remaining H atoms were positioned geometrically with C-H = 0.95, 0.99 and 0.98 Å, for aromatic, methylene and methyl H atoms, respectively, and constrained to ride on their parent atoms, with U iso (H) = xU eq (C), where x = 1.5 for methyl H and x = 1.2 for all other H atoms. Fig. 1 . The molecular structure of the title molecule, with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. 
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